{
    "N/R/U": null,
    "Applicant": "Novo Nordisk Inc.",
    "BLA Number": "203314",
    "Proprietary Name": "Tresiba",
    "Proper Name": "insulin degludec",
    "BLA Type": "351(a)",
    "Strength": "600UNITS/3ML (200UNITS/ML)",
    "Dosage Form": "Injection ",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Autoinjector",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "September 25, 2015",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": null,
    "Submission Type": "Original",
    "License Number": "1261",
    "Product Number": "002",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "insulin degludec",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_145810"
        }
    ]
}